News
Lessons for patients with MS and COVID-19
September 12, 2020
Patients with MS and COVID-19 avoided disease reactivation with combined PCR-serology testing and continued MS therapies with good results.
News
Distinguishing COVID-19 from flu in kids remains challenging
September 11, 2020
Clinicians need to prepare for managing coinfections of COVID-19 with flu and/or other respiratory viral infections in the upcoming flu season.
News
AI can pinpoint COVID-19 from chest x-rays
September 11, 2020
“We were able to separate the COVID-19 patients with very high fidelity.”
![1]()
News
Social distancing impacts other infectious diseases
September 11, 2020
Social distancing had a significant impact on each of the 12 commonly diagnosed infectious diseases analyzed.
![1]()
News
Dangers behind antimaskers and antivaxxers: How to combat both
September 10, 2020
Just as antivaxxers work to swing the opinion of the vaccine-hesitant, anti-maskers are vying with public health advocates for the support of the mask-hesitant, according to one physician.
![1]()
News
U.S. tops 500,000 COVID-19 cases in children
September 9, 2020
Milestone provides “a chilling reminder of why we need to take this virus seriously,” said the AAP president.
![1]()
News
Mounting data support COVID-19 acute pancreatitis
September 9, 2020
“It has become increasingly clear that COVID-19 has systemic effects that also includes the gastrointestinal and pancreaticobiliary systems,” the investigators wrote.
![1]()
News
Tools emerging to predict liver failure in cirrhosis
September 9, 2020
Systemic inflammation, with high levels of proteins, is one of the mechanisms that leads to organ failure.
News
Deaths sky high in hospitalized COVID patients with kidney injury
September 9, 2020
“We may be facing an epidemic of post–COVID-19 kidney disease and that, in turn, could mean much greater numbers of patients who require kidney dialysis and even transplants.”
News
Could these old drugs help fight COVID-19 and save lives?
September 9, 2020
“The beauty of a repurposed drug is that if you can get funding and start enrolling patients, you could potentially find out fairly quickly, as early as a few months, if that drug has an antiviral effect or not.”
